Novartis concludes Altitude study with Rasilez/Tekturna
Novartis has decided to conclude the Altitude study with Rasilez/Tekturna (aliskiren), on the recommendation of the independent data monitoring committee overseeing the trial. (Source: Drug Development Technology)div id=medwormpbiMedWorm Message:/i/b Find the best a href=http://www.januarysales.org/ target=_blankJanuary Sales/a in the UK./p/div

No Evidence To Support 'Economy Class Syndrome' In New DVT Guidelines
Oral contraceptives, sitting in a window seat, advanced age, and pregnancy increase DVT risk in long-distance travelers New evidence-based guidelines from the American College of Chest Physicians (ACCP) address the many risk factors for developing a deep vein thrombosis (DVT), or blood clot, as the result of long-distance travel. These risk factors include the use of oral contraceptives, sitting in a window seat, advanced age, and pregnancy... (Source: Health News from Medical News Today)